To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

HR 679 (119th Congress) is federal legislation introduced in the U.S. House of Representatives on January 23, 2025. Sponsored by Rep. Harshbarger, Diana [R-TN-1]. Current status: Referred to the House Committee on Energy and Commerce. (2025-01-23).